- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03238118
Attention Bias Modification, Attention Control and Psychoeducation for Irritability in Children and Adolescents
Randomized Clinical Trial Comparing Attention Bias Modification, Attention Control and Psychoeducation for Irritability in Children and Adolescents
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
RIO Grande DO SUL
-
Porto Alegre, RIO Grande DO SUL, Brazil, 90460-110
- Paola Paganella Laporte
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- children aged 9 to 12 years with symptoms of irritability who scored above the 90% percentile for their existing symptoms on Affective Reactivity Index
Exclusion Criteria:
- a diagnosis of intellectual disability.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Attention bias modification training
For attention-toward-positive, stimuli are colour-pictures of 16 angry and 16 happy faces (half female).
Each happy face is presented 10 times, and each angry face presented 80 times across trials, balanced across the different positions in the 3 × 3 matrix.
This yielded 160 training trials (two blocks of 80 trials).
Children had to mouse-click on the happy face within the 3 × 3 matrix of angry faces as quickly and as accurately as possible.
The matrix disappeared after the child mouse-clicked on the correct face and the next trial began.
|
Participants will complete the assigned attention-training task three times a week for two weeks (six sessions), yielding 960 trials. Each session consists of three parts: evaluating the individual baseline, training and testing. Participants will also be required to complete a self-report assessment before and after each session. Participants will be evaluated at baseline, the end of week 1 and at the end of week 2 by blind investigators. Psychoeducation Participants will receive psychoeducation once a week for two weeks. Participants will also be required to complete a self-report assessment before and after each session of psychoeducation. Participants will be evaluated at baseline, the end of week 1 and at the end of week 2 by blind investigators.
Participants will receive psychoeducation once a week for two weeks.
Participants will also be required to complete a self-report assessment before and after each session of psychoeducation.
Participants will be evaluated at baseline, the end of week 1 and at the end of week 2.
|
|
PLACEBO_COMPARATOR: Attention Control Training
For attention-training-control, stimuli are 20 colour-pictures of individual birds and flowers used in prior visual-search tasks with children.
Children mouse-clicked on the bird presented amongst flowers as quickly and accurately as possible.
Other task parameters were similar to the attention-toward-positive task (160 training trials).
No performance feedback is given in either condition.
|
Participants will receive psychoeducation once a week for two weeks.
Participants will also be required to complete a self-report assessment before and after each session of psychoeducation.
Participants will be evaluated at baseline, the end of week 1 and at the end of week 2.
Attention Control Training Participants will complete the assigned attention-training task three times a week for two weeks (six sessions), yielding 960 trials. Each session consists of three parts: evaluating the individual baseline, training and testing. Participants will also be required to complete a self-report assessment before and after each session. Participants will be evaluated at baseline, the end of week 1 and at the end of week 2 by blind investigators. Psychoeducation Participants will receive psychoeducation once a week for two weeks. Participants will also be required to complete a self-report assessment before and after each session of psychoeducation. Participants will be evaluated at baseline, the end of week 1 and at the end of week 2 by blind investigators. |
|
PLACEBO_COMPARATOR: Psychoeducation
Psychoeducation is an intervention that is characterized by informing the participant of their irritability symptoms.
The goal is to teach participants how to understand their symptoms, explain their treatment modalities, recognize signs that may lead to a possible crisis, and provide tips and strategies on how to deal with irritability.
|
Participants will receive psychoeducation once a week for two weeks.
Participants will also be required to complete a self-report assessment before and after each session of psychoeducation.
Participants will be evaluated at baseline, the end of week 1 and at the end of week 2.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean change from baseline to endpoint in the "Irritability Subscale" of The Multidimensional Assessment of Preschool Disruptive Behavior (mean values)
Time Frame: two weeks
|
The Multidimensional Assessment of Preschool Disruptive Behavior is a developmentally sensitive questionnaire, which is used to assess temper loss in terms of tantrum features and anger regulation.
A total of 39 items are rated in terms of frequency over the past month: 0 = Never in the past month; 1 = Rarely (less than weekly); 2 = Some days (1-3 days per week); 3 = Most days (4-6 days); 4 = Daily; and 5 = Multiple times per day.
|
two weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean change from baseline to endpoint in the Affective Reactivity Index
Time Frame: two weeks
|
The Affective Reactivity individual items are scored 0,1, 2, and only the first six items are summed to form the total score - the seventh is an impairment item and it is analyzed separately.
|
two weeks
|
|
Mean change from baseline to endpoint in The Extended Strengths and Weaknesses Assessment of Normal Behavior
Time Frame: two weeks
|
The Extended Strengths and Weaknesses Assessment of Normal Behavior has been developed in order to capture variance associated with both strengths and weaknesses to generate a near-normal distribution in epidemiological samples.
For each of the 30 items, evaluators assess how well the child handles emotions and behaves compared to other children of the same age - far below average, below average, slightly below average, about average, slightly above average, above average and far above average.
|
two weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety: The parent- and child-report formats of the Spence Children's Anxiety Scale
Time Frame: two weeks
|
The Extended Strengths and Weaknesses Assessment of Normal Behavior has been developed in order to capture variance associated with both strengths and weaknesses to generate a near-normal distribution in epidemiological samples.
For each of the 30 items, evaluators assess how well the child handles emotions and behaves compared to other children of the same age - far below average, below average, slightly below average, about average, slightly above average, above average and far above average.
|
two weeks
|
|
Depression: Mood and Feelings Questionnaire
Time Frame: two weeks
|
The Mood and Feelings Questionnaire is a 33-item questionnaire based on "Diagnostic and Statistical Manual of Mental Disorders" (DSM)-III-R criteria for depression.
Consists of a series of descriptive phrases regarding how the subject has been feeling or acting recently.
Codings reflect whether the phrase was descriptive of the subject most of the time, sometimes, or not at all in the past two weeks.
|
two weeks
|
|
Attention-Deficit/Hyperactivity Disorder: The Multimodal Treatment Study for Attention-Deficit/Hyperactivity Disorder Swanson - Version IV
Time Frame: two weeks
|
The items from the DSM-IV (1994) criteria for Attention-Deficit/Hyperactivity Disorder are included for the two subsets of symptoms: inattention (items 1-9) and hyperactivity/impulsivity (items 11-19).
Also, items are included from the DSM-IV criteria for Oppositional Defiant Disorder (items 21-28) since it often is present in children with Attention-Deficit/Hyperactivity Disorder.
|
two weeks
|
|
Profile of Mood State
Time Frame: two weeks
|
The Profile of Mood State contains 65 adjectives rated by participants on a 5-point scale.
Six factors are derived that include tension, depression, anger, fatigue, vigor and confusion.
|
two weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Giovanni Salum, Federal University of Rio Grande do Sul
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 39602514700005327
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Irritability
-
National Institute of Mental Health (NIMH)Recruiting
-
National Institute of Mental Health (NIMH)RecruitingIrritabilityUnited States
-
Kley Hertz S/ACompleted
-
Kley Hertz S/ACompleted
-
Kley Hertz S/AUnknown
-
University of North Carolina, Chapel HillFoundation of Hope for the Research and Treatment of Mental IllnessNot yet recruitingIrritability | Depression - Major Depressive DisorderUnited States
-
Kley Hertz S/AUnknown
-
University of OxfordWellcome Trust; Oxford Health Biomedical Research Centre (OH BRC) support schemeRecruitingDepression | Irritability | Depression - Major Depressive DisorderUnited Kingdom
-
Karuna Therapeutics, Inc., a Bristol Myers Squibb...Karuna Therapeutics, Inc., a Bristol Myers Squibb companyRecruitingSchizophrenia | Autism-Related IrritabilityUnited States, Japan, Argentina, Romania, Canada, France, Germany, Hungary, Poland, Spain
-
Geha Mental Health CenterChief Scientist, The Israel Ministry of ScienceCompletedAnger | Suicidal Ideation | Irritability | Suicidal Behavior | Externalizing BehaviorIsrael
Clinical Trials on Attention bias modification training
-
Humboldt-Universität zu BerlinCompletedObsessive-Compulsive DisorderGermany
-
University of Texas at AustinArcade TherapeuticsRecruiting
-
Palo Alto UniversityTerminated
-
University of OsloDiakonhjemmet Hospital; University of Oxford; ExtrastiftelsenCompletedMajor Depressive DisorderNorway
-
Creighton UniversityAt Ease USACompletedPosttraumatic Stress DisorderUnited States
-
University of PittsburghNational Institute of Mental Health (NIMH)Completed
-
University of OsloDiakonhjemmet Hospital; University of Oxford; Sorlandet Hospital HFCompleted
-
University of California, Los AngelesCompleted
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedObsessive Compulsive DisorderUnited States
-
University of Texas at AustinNational Institute of Mental Health (NIMH)Completed